Myopia, Progressive
45
3
14
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 45 trials
100.0%
+13.5% vs benchmark
4%
2 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (45)
Choroidal Response to Novel Spectacle Lens to Control Myopia Progression
Novel Lenses for Myopia Progression Trial
Evaluation of the Safety and Efficacy of the D.D.C Dual-control Technology Spectacle Lenses in Delaying the Progression of Myopia: a Randomized Controlled Trial
Safety and Efficacy of Blue Star MAX-5 Lenses in Myopia Control
Stellest Lens Wear in Adult Progressing Myopes
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
Multicenter RCT: LED Red Light Dose-Response in Myopia Progression Control
Myopia Progression With Freeform Myopia Control Spectacles
Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
Impact of Digital Screen Time in Progression of Myopia in Children
Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.
Low-dose Atropine for Myopia Control in Children
Management of Myopia in University Students Using Dual Focus Soft Contact Lenses
Kubota Glass Parameter Refinement Study
Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
Effect of Virtual Reality-Based Visual Training for Myopia Control in Children
Effect of Atropine on Pupil Size and Quality of Vision
Clinical Evaluation of MyoCare in Europe (CEME)